CVS Health (NYSE:CVS) Updates FY 2025 Earnings Guidance

CVS Health (NYSE:CVS) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 5.750-6.000 for the period, compared to the consensus EPS estimate of 5.970. The company issued revenue guidance of -.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Royal Bank of Canada cut their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Piper Sandler reduced their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. TD Cowen raised their price target on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. UBS Group reduced their price objective on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, Barclays dropped their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $67.78.

CVS Health Stock Up 15.8 %

Shares of NYSE:CVS traded up $8.71 on Wednesday, hitting $63.71. 11,981,160 shares of the company traded hands, compared to its average volume of 12,304,292. The company has a market cap of $80.18 billion, a PE ratio of 16.13, a PEG ratio of 0.60 and a beta of 0.61. The stock has a 50 day simple moving average of $50.61 and a 200-day simple moving average of $55.92. CVS Health has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, research analysts expect that CVS Health will post 5.14 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.17%. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.